Author

Gregory L. Wheeler

Nationwide Children's HospitalORCID 0000-0002-3291-6537Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetics· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Afrooz RashnonejadiD· 1 shared Allison M. BradburyiD· 1 shared Ben Kelly· 1 shared Burçak ÖzeşiD· 1 shared Cathal SeoigheiD· 1 shared Colin T. MaguireiD· 1 shared Devi Jaganathan· 1 shared Ebru Erzurumluoğlu GökalpiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Afrooz RashnonejadORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintOct 8, 2026

A gene-centric analysis of copy number variation reveals tumour suppressor modulation of cancer risk and novel associations with common diseases

Sophie Matthews, Cathal Seoighe, Gregory L. Wheeler

This study uses a gene-centric analysis of copy number variation to identify associations between gene deletions and cancer risk, as well as novel links to common diseases.

DOI 10.64898/2026.10.06.757170

humanwhole-genome sequencing

𝕏 PostBluesky

GeneticsbioRxivPreprintMay 29, 2025

REMEDY: REpair of heterozygous Mutations independent of Exogenous Donor template with high efficiency using allele specific CRISPR targeting and HDR enhancers

Yasemin Sezgin, Genesis Snyder, Noushin Saljoughian…·Meisam Naeimi Kararoudi

REMEDY enables efficient repair of heterozygous mutations in human and mouse cells without exogenous donor DNA by using CRISPR-induced DSBs and HDR enhancers.

DOI 10.1101/2025.05.29.641201

humanmouse

𝕏 PostBluesky